Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John J Ryan

Showing results (41-50 of 234) with videos related to

Pageof 24
Sort By:
Journal of Toxicology and Environmental Health. Part A|December 10, 2002
Guidelines for analysis of human milk for environmental chemicalsLarry L Needham, John J Ryan, Peter Fürst, et al.
Pulmonary Circulation|July 7, 2022
Differentiating pulmonary hypertension associated with protein kinase inhibitorsJoshua A Jacobs, Eiman Jahangir, John J Ryan
The Canadian Journal of Cardiology|October 25, 2011
Pulmonary endarterectomy surgery--a technically demanding cure for WHO Group IV Pulmonary Hypertension: requirements for centres of excellence and availability in CanadaJohn J Ryan, Stuart Rich, Stephen L Archer
Circulation. Cardiovascular Genetics|February 21, 2013
Top advances in functional genomics and translational biology for 2012John J Ryan, Kiran Musunuru, Siddharth K Prakash
Handbook of Experimental Pharmacology|October 5, 2013
Rodent models of group 1 pulmonary hypertensionJohn J Ryan, Glenn Marsboom, Stephen L Archer
Molecular Pharmacology|November 9, 2005
Biological consequences of trinuclear platinum complexes: comparison of [[trans-PtCl(NH3)2]2mu-(trans-Pt(NH3)2(H2N(CH2)6-NH2)2)]4+ (BBR 3464) with its noncovalent congenersAmanda L Harris, John J Ryan, Nicholas Farrell
Circulation Research|August 20, 2011
Paracrine proliferative signaling by senescent cells in world health organization group 3 pulmonary hypertension: age corrupting youth?John J Ryan, Jalees Rehman, Stephen L Archer
Drugs|April 5, 2023
Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?Ayedh K Alamri, Christy L Ma, John J Ryan
Heart Failure Clinics|July 1, 2014
Current therapeutic approach in heart failure with preserved ejection fractionJose Nativi-Nicolau, John J Ryan, James C Fang
Circulation. Cardiovascular Quality and Outcomes|January 22, 2015
Building the case for novel clinical trials in pulmonary arterial hypertensionJohn J Ryan, Jonathan D Rich, Bradley A Maron
Pageof 24

Showing results (41-50 of 234) with videos related to

Sort By:
Pageof 24
Journal of Toxicology and Environmental Health. Part A|December 10, 2002
Guidelines for analysis of human milk for environmental chemicalsLarry L Needham, John J Ryan, Peter Fürst, et al.
Pulmonary Circulation|July 7, 2022
Differentiating pulmonary hypertension associated with protein kinase inhibitorsJoshua A Jacobs, Eiman Jahangir, John J Ryan
The Canadian Journal of Cardiology|October 25, 2011
Pulmonary endarterectomy surgery--a technically demanding cure for WHO Group IV Pulmonary Hypertension: requirements for centres of excellence and availability in CanadaJohn J Ryan, Stuart Rich, Stephen L Archer
Circulation. Cardiovascular Genetics|February 21, 2013
Top advances in functional genomics and translational biology for 2012John J Ryan, Kiran Musunuru, Siddharth K Prakash
Handbook of Experimental Pharmacology|October 5, 2013
Rodent models of group 1 pulmonary hypertensionJohn J Ryan, Glenn Marsboom, Stephen L Archer
Molecular Pharmacology|November 9, 2005
Biological consequences of trinuclear platinum complexes: comparison of [[trans-PtCl(NH3)2]2mu-(trans-Pt(NH3)2(H2N(CH2)6-NH2)2)]4+ (BBR 3464) with its noncovalent congenersAmanda L Harris, John J Ryan, Nicholas Farrell
Circulation Research|August 20, 2011
Paracrine proliferative signaling by senescent cells in world health organization group 3 pulmonary hypertension: age corrupting youth?John J Ryan, Jalees Rehman, Stephen L Archer
Drugs|April 5, 2023
Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?Ayedh K Alamri, Christy L Ma, John J Ryan
Heart Failure Clinics|July 1, 2014
Current therapeutic approach in heart failure with preserved ejection fractionJose Nativi-Nicolau, John J Ryan, James C Fang
Circulation. Cardiovascular Quality and Outcomes|January 22, 2015
Building the case for novel clinical trials in pulmonary arterial hypertensionJohn J Ryan, Jonathan D Rich, Bradley A Maron
Pageof 24